| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
49,039 |
41,749 |
$5.95M |
| G0378 |
Hospital observation service, per hour |
5,502 |
3,079 |
$1.44M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,220 |
3,329 |
$1.22M |
| G0379 |
Direct admission of patient for hospital observation care |
2,746 |
2,154 |
$1.11M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,394 |
5,609 |
$954K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,219 |
9,625 |
$827K |
| A0425 |
Ground mileage, per statute mile |
14,202 |
10,790 |
$734K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
7,876 |
6,288 |
$546K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,374 |
12,915 |
$517K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,056 |
8,926 |
$500K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,296 |
6,969 |
$428K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,566 |
14,982 |
$417K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,629 |
8,616 |
$404K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,940 |
1,665 |
$386K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,720 |
1,531 |
$379K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,995 |
4,527 |
$345K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
973 |
909 |
$335K |
| 59025 |
Fetal non-stress test |
2,831 |
1,677 |
$238K |
| 80050 |
General health panel |
5,869 |
5,068 |
$225K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,494 |
4,987 |
$218K |
| 80053 |
Comprehensive metabolic panel |
29,502 |
24,037 |
$203K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,756 |
31,922 |
$203K |
| 71045 |
Radiologic examination, chest; single view |
6,443 |
5,441 |
$200K |
| 93017 |
|
1,455 |
1,293 |
$188K |
| 71046 |
Radiologic examination, chest; 2 views |
3,292 |
2,887 |
$153K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
438 |
394 |
$150K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,648 |
1,390 |
$125K |
| 36415 |
Collection of venous blood by venipuncture |
70,815 |
52,835 |
$122K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
858 |
780 |
$114K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,499 |
6,283 |
$109K |
| 76801 |
|
761 |
612 |
$106K |
| 97597 |
|
1,957 |
851 |
$103K |
| 20610 |
|
802 |
629 |
$89K |
| 81025 |
|
12,819 |
10,888 |
$89K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,302 |
1,007 |
$84K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
671 |
503 |
$82K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,907 |
2,991 |
$81K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,701 |
3,860 |
$70K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,735 |
2,197 |
$63K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,312 |
1,836 |
$61K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,280 |
1,812 |
$60K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
94 |
84 |
$58K |
| 87390 |
|
3,123 |
2,337 |
$53K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
315 |
269 |
$51K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,405 |
1,075 |
$50K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,909 |
2,468 |
$50K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
594 |
445 |
$50K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,885 |
1,465 |
$49K |
| 73562 |
|
748 |
474 |
$45K |
| 84439 |
|
7,214 |
5,955 |
$45K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
558 |
310 |
$44K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
212 |
128 |
$42K |
| 83880 |
|
2,319 |
1,983 |
$42K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,650 |
1,479 |
$41K |
| 81003 |
|
30,981 |
23,246 |
$39K |
| 94726 |
|
370 |
314 |
$37K |
| 80061 |
Lipid panel |
3,271 |
2,919 |
$36K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
387 |
325 |
$36K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,105 |
4,216 |
$34K |
| 85730 |
|
8,881 |
7,472 |
$34K |
| 83970 |
|
1,372 |
1,180 |
$33K |
| 81001 |
|
17,315 |
13,557 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
381 |
368 |
$31K |
| 86703 |
|
3,124 |
2,337 |
$30K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,628 |
1,358 |
$30K |
| 95117 |
|
2,627 |
681 |
$28K |
| 84484 |
|
4,653 |
3,619 |
$28K |
| 85610 |
|
9,461 |
7,997 |
$26K |
| 84702 |
|
2,437 |
1,708 |
$26K |
| 76830 |
Ultrasound, transvaginal |
185 |
151 |
$26K |
| 84144 |
|
1,693 |
1,279 |
$25K |
| 83690 |
|
4,864 |
4,183 |
$24K |
| 94729 |
|
382 |
324 |
$23K |
| 86803 |
|
1,870 |
1,386 |
$18K |
| 86885 |
|
3,031 |
1,337 |
$18K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,052 |
1,726 |
$18K |
| 82553 |
|
2,898 |
2,326 |
$17K |
| 87340 |
|
2,252 |
1,665 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,432 |
1,170 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,807 |
2,894 |
$15K |
| 87070 |
|
2,401 |
2,007 |
$15K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
90 |
77 |
$15K |
| 86762 |
|
1,577 |
1,007 |
$14K |
| 86592 |
|
3,869 |
2,964 |
$12K |
| 82150 |
|
2,702 |
2,342 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,117 |
1,723 |
$12K |
| 87088 |
|
2,089 |
1,701 |
$12K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
584 |
342 |
$12K |
| 99215 |
Prolong outpt/office vis |
214 |
153 |
$11K |
| 73564 |
|
150 |
93 |
$11K |
| 83020 |
|
1,178 |
871 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,125 |
1,776 |
$11K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
656 |
577 |
$11K |
| 82550 |
|
2,894 |
2,468 |
$11K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
31 |
27 |
$9K |
| 94010 |
|
166 |
138 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
419 |
313 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
206 |
172 |
$8K |
| 83735 |
|
2,364 |
2,008 |
$8K |
| 73630 |
|
205 |
150 |
$8K |
| 73560 |
|
128 |
98 |
$8K |
| 80069 |
|
1,478 |
1,260 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
376 |
266 |
$7K |
| 74018 |
|
128 |
104 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
101 |
37 |
$6K |
| 96376 |
|
122 |
64 |
$6K |
| 73130 |
|
109 |
65 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
374 |
341 |
$6K |
| 73502 |
|
102 |
64 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
33 |
26 |
$6K |
| 80076 |
|
1,165 |
971 |
$5K |
| 74240 |
|
59 |
57 |
$5K |
| 81000 |
|
1,880 |
1,452 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
453 |
370 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
12 |
$5K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
261 |
165 |
$5K |
| 73110 |
|
108 |
65 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
476 |
381 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
17 |
12 |
$4K |
| 84100 |
|
1,695 |
1,433 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
958 |
721 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
56 |
45 |
$4K |
| 82570 |
|
1,319 |
1,134 |
$4K |
| 71250 |
|
16 |
13 |
$4K |
| 73030 |
|
72 |
50 |
$4K |
| 80305 |
|
315 |
258 |
$4K |
| 93225 |
|
93 |
66 |
$4K |
| 93226 |
|
92 |
66 |
$4K |
| 86901 |
|
1,929 |
1,346 |
$4K |
| 86900 |
|
1,943 |
1,346 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
105 |
87 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
215 |
123 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
23 |
12 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
28 |
26 |
$3K |
| 82105 |
|
221 |
193 |
$3K |
| 86756 |
|
226 |
204 |
$3K |
| 87040 |
|
395 |
215 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
189 |
168 |
$3K |
| 20553 |
|
6,237 |
4,620 |
$3K |
| 99385 |
|
175 |
95 |
$3K |
| 95024 |
|
92 |
69 |
$2K |
| 0012A |
|
145 |
74 |
$2K |
| 84156 |
|
1,112 |
967 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
20 |
14 |
$2K |
| 93296 |
|
180 |
161 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,161 |
3,765 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,666 |
1,171 |
$2K |
| 74019 |
|
28 |
26 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
450 |
322 |
$2K |
| 76770 |
|
40 |
36 |
$2K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
75 |
48 |
$2K |
| 82950 |
|
360 |
300 |
$2K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
61 |
54 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
47 |
42 |
$2K |
| 0002A |
|
108 |
51 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,717 |
2,165 |
$1K |
| 99205 |
Prolong outpt/office vis |
41 |
33 |
$1K |
| 86769 |
|
42 |
30 |
$1K |
| 73565 |
|
733 |
368 |
$1K |
| 0001A |
|
207 |
75 |
$1K |
| 86677 |
|
97 |
24 |
$997.35 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
236 |
171 |
$991.44 |
| 84146 |
|
67 |
52 |
$912.49 |
| 76942 |
|
16 |
13 |
$790.51 |
| 83605 |
|
112 |
98 |
$759.00 |
| 72100 |
|
18 |
14 |
$737.49 |
| 76820 |
|
32 |
12 |
$731.75 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
70 |
45 |
$673.63 |
| 0011A |
|
66 |
42 |
$636.13 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,988 |
6,697 |
$562.20 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
50 |
39 |
$556.52 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$530.40 |
| J3490 |
Unclassified drugs |
2,923 |
2,321 |
$503.95 |
| 82728 |
|
63 |
53 |
$492.47 |
| 85651 |
|
174 |
135 |
$476.07 |
| 87075 |
|
93 |
69 |
$464.72 |
| 82077 |
|
36 |
27 |
$446.25 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
728 |
440 |
$425.97 |
| 87077 |
|
85 |
79 |
$415.49 |
| 84410 |
|
21 |
12 |
$410.34 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
39 |
33 |
$406.13 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
402 |
273 |
$384.95 |
| 85378 |
|
60 |
51 |
$358.48 |
| 87186 |
|
71 |
65 |
$340.66 |
| 84403 |
|
19 |
13 |
$335.54 |
| 84134 |
|
89 |
74 |
$302.97 |
| 86140 |
|
104 |
86 |
$298.06 |
| 82962 |
|
98 |
81 |
$260.70 |
| 82627 |
|
15 |
12 |
$244.53 |
| 83001 |
|
18 |
13 |
$222.97 |
| 83002 |
|
18 |
13 |
$222.25 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
413 |
338 |
$198.77 |
| 82785 |
|
22 |
15 |
$197.52 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
94 |
81 |
$174.38 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
42 |
37 |
$152.87 |
| Q3014 |
Telehealth originating site facility fee |
425 |
381 |
$149.59 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
22 |
13 |
$146.37 |
| 83540 |
|
29 |
27 |
$129.40 |
| 84402 |
|
27 |
13 |
$101.89 |
| 87205 |
|
78 |
58 |
$94.60 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
97 |
78 |
$85.47 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
80 |
45 |
$77.80 |
| 82043 |
|
12 |
12 |
$69.36 |
| 91301 |
|
209 |
98 |
$53.36 |
| 83550 |
|
12 |
12 |
$43.70 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
12 |
$35.82 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,541 |
2,024 |
$31.11 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
16 |
13 |
$26.51 |
| 91300 |
|
216 |
103 |
$15.92 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
40 |
35 |
$8.58 |
| 90837 |
Psychotherapy, 53 minutes with patient |
57 |
54 |
$0.00 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
24 |
24 |
$0.00 |
| 00000 |
|
1,047 |
855 |
$0.00 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
15 |
12 |
$0.00 |
| 02024 |
|
12 |
12 |
$0.00 |